DOI: 10.2337/dc06-0243 © 2006 by the American Diabetes Association
Brain Aging in Very Old Men With Type 2 DiabetesThe Honolulu-Asia Aging Study
1 Neurology and Alzheimer Center, Vrije Universiteit Medical Center, De Boelelaan, Amsterdam, the Netherlands Address correspondence and reprint requests to Lenore J. Launer, Laboratory of Epidemiology, Demography, and Biometry, NIA, 7201 Wisconsin Ave., Room 3C-309, Bethesda, MD 20892. E-mail: launerl{at}nia.nih.gov OBJECTIVEType 2 diabetes leads to cognitive impairment and dementia, which may reflect microvascular and macrovascular complications as well as neurodegenerative processes. There are few studies on the anatomical basis for loss of cognitive function in type 2 diabetes. The objective of this study was to investigate the association between type 2 diabetes and markers of brain aging on magnetic resonance images, including infarcts, lacunes, and white matter hyperintensities as markers of vascular damage and general and hippocampal atrophy as markers of neurodegeneration in Japanese-American men born between 1900 and 1919 and followed since 1965 in the Honolulu-Asia Aging Study. RESEARCH DESIGN AND METHODSPrevalent and incident dementia was assessed. Associations between magnetic resonance imaging markers and diabetic status were estimated with logistic regression, controlling for sociodemographic and other vascular factors. RESULTSThe prevalence of type 2 diabetes in the cohort is 38%. Subjects with type 2 diabetes had a moderately elevated risk for lacunes (odds ratio [OR] 1.6 [95% CI 1.02.6]) and hippocampal atrophy (1.7 [0.92.9]). The risk for both hippocampal atrophy and lacunes/infarcts was twice as high in subjects with compared with those without type 2 diabetes. Among the group with type 2 diabetes, those with the longest duration of diabetes, those taking insulin, and those with complications had relatively more pathologic brain changes. CONCLUSIONSThere is evidence that older individuals with type 2 diabetes have an elevated risk for vascular brain damage and neurodegenerative changes. These pathological changes may be the anatomical basis for an increased risk of cognitive impairment or dementia in type 2 diabetes.
Abbreviations: ABI, ankle-brachial index apo, apolipoprotein CHD, coronary heart disease FOV, field of view HAAS, Honolulu-Asia Aging Study IDE, insulin-degrading enzyme IGT, impaired glucose tolerance MRI, magnetic resonance imaging NFT, neurofibrillary tangle TICV, total intracranial volume WMH, white matter hyperintensity
|
|
|
|||||||||||||||||||||||||||